Global Asthma Therapeutics Market 2016-2020

  • Published: Jul 2016
  • Pages: 110
  • SKU: IRTNTR10076

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This industry research report identifies AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, and Merck as the key vendors in the global asthma therapeutics market. This report also presents a competitive analysis of the market by type of treatment, by drug class, by route of administration, and by geography.

Overview of the global asthma therapeutics market

Market research analysts at Technavio have predicted that the global asthma therapeutics market will grow steadily over the next four years and post an impressive revenue of more than USD 22 billion by 2020. Owing to the development of target specific drugs, there will be a high demand for monoclonal antibodies for the treatment of asthma. Monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines are important in the initiation and persistence of asthmatic inflammation. Xolair was the first mAb to be approved for the treatment of allergic asthma and recorded huge sales right after approval. Since several manufacturers are currently focusing on the development of other mAbs, the forecast period will see the introduction of several new products. And owing to the better efficacy of these drugs over other small molecules, there will be an upsurge in their demand contributing to the growth of the asthma drugs market.

The Americas will account for more than 45% of the total share of the market and dominate the industry during the forecast period. The increase in pollution and the presence of a huge asthmatic population in the Latin American countries are identified to be the major factors that will augment the demand for asthmatic drugs from this region. Also, the introduction of new healthcare reforms of various countries in the region have resulted in reducing the cost of pharmaceutical drugs, providing increased access and quality of healthcare, and offer insurance coverage for individuals of all ages, which will, in turn, fuel the growth of the market in this region.

Competitive landscape and key vendors

Owing to the presence of several well established and small scale vendors, this market appears to be highly fragmented. Key players such as GSK, AstraZeneca, Boehringer Ingelheim, F.Hoffmann-La Roche, and Merck have a great product portfolio and account for the major revenue shares. The competition among vendors is intense and the leading vendors have also started acquiring small regional vendors to increase their share of the market. The coming years will witness a number of mergers and acquisitions and innovative product launches, which will further intensify the competitive environment in the market.

The leading vendors in the market are -

  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GSK
  • Merck

The other prominent vendors in the market are ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Atopix Therapeutics, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, and Whanin Pharmaceutical.

Segmentation by type of treatment and analysis of the asthma therapeutics market

  • Preventive medication
  • Quick-relief medication

During 2015, the preventive medications segment accounted for about 65% of the total market share and dominated this market. These medications are also called controller medications and help in the prevention of asthma attacks on a long-term basis. The continuous use of these medications results in less inflamed airways and controls the chronic symptoms of asthma. As a result, these are an essential treatment for most asthma patients and will have a constant demand in the next four years as well.

Segmentation by route of administration and analysis of the asthma therapeutics market

  • Inhalation
  • Parenteral
  • Oral

Since the onset of action is quick with systemic and local effect by inhalation, this mode of administration will account for major shares of the market and dominate the asthma treatment drugs industry throughout the forecast period.  Drug administration by this mode happens in a phased manner, and many of the pipeline products for the treatment of asthma are also being developed for administering via inhalation.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global asthma therapeutics market?
  • What are the key market trends impacting the growth of the global asthma therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global asthma therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global asthma therapeutics market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global asthma therapeutics market

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Breakthrough in asthma research
  • Asthma: An overview

PART 05: Pipeline portfolio

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Key buying criteria for asthma drugs

PART 08: Market segmentation by type of treatment

  • Preventive medications
  • Quick-relief medications
  • Others

PART 09: Market segmentation by drug class

  • Combination therapies
  • Bronchodilators
  • Immunosuppressants
  • Leukotriene antagonists
  • Mast cell stabilizers

PART 10: Segmentation by route of administration

  • Inhalation
  • Parenteral
  • Oral

PART 11: Drug delivery devices market for asthma drugs 

  • Market overview
  • Market segmentation by product type

PART 12: Geographical segmentation

  • Global asthma therapeutics market by geography 2015-2020
  • Asthma therapeutics market in Americas
  • Asthma therapeutics market in EMEA
  • Asthma therapeutics market in APAC

PART 13: Market drivers

  • Huge market potential for mAbs
  • New product approvals minimizing the impact of generic erosion
  • Increasing rate of allergies due to environmental pollution

PART 14: Impact of drivers

PART 15: Market challenges

  • Increased preference for CAM
  • Poor patient adherence toward controller medications
  • Presence of different phenotypes of asthma leading to prescription errors

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Innovative technologies for drug delivery
  • Growing adoption of immunotherapies
  • Shift toward immune/inflammatory system targets from glucocorticoid and adrenergic receptors
  • Increase in online marketing services
  • Growing use of home healthcare devices

PART 18: Vendor landscape

  • Competitive scenario
  • Key news

PART 19: Key vendor analysis

  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GSK
  • Merck
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>